Penumbra, Inc (PEN) Current Ratio
- Current ratio · latest quarter: Value 5.75×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 5.75× | Current assets / current liabilities. $1.34B ÷ $233.78M ≈ 5.75× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 1.34B USD | Assets, Current |
| Current obligations | 233.78M USD | Liabilities, Current |
| Cash and equivalents | 205.27M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 453.52M USD | Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current |
| Customer receivables | 190.41M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 442.65M USD | Inventory, Net |
| Payables | 44.73M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.34B | $233.78M | $205.27M | $453.52M | $190.41M | $442.65M | $44.73M | (m) | 5.75× |
| 2026-03-31 | $1.28B | $211.73M | $241.29M | $374.37M | $183.29M | $438.54M | $43.66M | (m) | 6.02× |
| 2025-12-31 | $1.22B | $183.13M | $186.90M | $357.92M | $190.02M | $431.55M | $34.74M | (m) | 6.64× |
| 2025-09-30 | $1.14B | $169.60M | $321.03M | $149.27M | $183.43M | $432.37M | $29.82M | (m) | 6.73× |
| 2025-06-30 | $1.07B | $157.76M | $421.77M | $2.79M | $175.54M | $427.63M | $28.12M | (m) | 6.75× |
| 2025-03-31 | $999.71M | $158.63M | $376.05M | $2.79M | $167.98M | $415.86M | $31.15M | (m) | 6.30× |
| 2024-12-31 | $951.13M | $158.34M | $324.40M | $15.73M | $167.67M | $406.74M | $31.33M | (m) | 6.01× |
| 2024-09-30 | $891.75M | $153.19M | $280.48M | $10.55M | $176.05M | $393.41M | $33.15M | (m) | 5.82× |
| 2024-06-30 | $943.79M | $150.99M | $288.33M | $51.36M | $200.83M | $373.80M | $32.82M | (m) | 6.25× |
| 2024-03-31 | $935.02M | $152.80M | $223.11M | $90.36M | $191.99M | $398.37M | $32.45M | (m) | 6.12× |
| 2023-12-31 | $915.40M | $151.14M | $167.49M | $121.70M | $201.77M | $388.02M | $27.16M | (m) | 6.06× |
| 2023-09-30 | $868.48M | $145.08M | $100.76M | $148.10M | $206.62M | $374.25M | $28.00M | (m) | 5.99× |
| 2023-06-30 | $827.88M | $144.12M | $114.17M | $106.90M | $208.97M | $358.77M | $25.82M | (m) | 5.74× |
| 2023-03-31 | $786.49M | $146.33M | $94.69M | $104.41M | $207.36M | $344.04M | $28.20M | (m) | 5.37× |
| 2022-12-31 | $755.70M | $144.93M | $69.86M | $118.17M | $203.38M | $334.01M | $26.68M | (m) | 5.21× |
| 2022-09-30 | $723.63M | $138.33M | $54.84M | $129.58M | $189.01M | $320.30M | $25.36M | (m) | 5.23× |
| 2022-06-30 | $717.96M | $145.60M | $58.23M | $146.13M | $187.39M | $295.88M | $23.10M | (m) | 4.93× |
| 2022-03-31 | $690.33M | $130.10M | $68.16M | $172.18M | $143.42M | $274.35M | $14.14M | (m) | 5.31× |
| 2021-12-31 | $681.47M | $123.20M | $59.38M | $195.50M | $133.94M | $263.50M | $13.42M | (m) | 5.53× |
| 2021-09-30 | $667.99M | $116.06M | $66.29M | $200.64M | $120.07M | $258.32M | $13.68M | (m) | 5.76× |
| 2021-03-31 | $635.13M | $111.86M | $55.63M | $186.98M | $126.42M | $245.32M | $15.39M | (m) | 5.68× |
| 2020-12-31 | $617.70M | $105.93M | $69.67M | $195.16M | $114.61M | $219.53M | $14.11M | (m) | 5.83× |
| 2020-09-30 | $590.20M | $108.06M | $80.11M | $188.61M | $112.82M | $191.55M | $14.54M | (m) | 5.46× |
| 2020-06-30 | $575.89M | $77.61M | $134.38M | $143.91M | $97.61M | $183.44M | $14.43M | (m) | 7.42× |
| 2020-03-31 | $453.74M | $88.07M | $72.46M | $95.77M | $103.96M | $166.15M | $15.84M | (m) | 5.15× |
| 2019-12-31 | $463.13M | $91.05M | $72.78M | $116.61M | $105.90M | $152.99M | $15.11M | (m) | 5.09× |
| 2019-09-30 | $451.33M | $86.17M | $111.58M | $82.86M | $101.83M | $140.36M | $11.96M | (m) | 5.24× |
| 2019-06-30 | $434.60M | $69.76M | $77.26M | $110.00M | $99.01M | $132.74M | $8.74M | (m) | 6.23× |
| 2019-03-31 | $423.09M | $69.41M | $95.61M | $99.24M | $94.68M | $121.69M | $7.69M | (m) | 6.10× |
| 2019-01-01 | $410.30M | $69.54M | (m) | (m) | (m) | (m) | (m) | (m) | 5.90× |
| 2018-12-31 | $410.73M | $66.06M | (m) | (m) | (m) | (m) | (m) | (m) | 6.22× |
| 2018-09-30 | $397.60M | $65.05M | $47.74M | $146.18M | $80.44M | $109.71M | $8.87M | (m) | 6.11× |
| 2018-06-30 | $392.50M | $49.69M | $59.70M | $147.19M | $74.06M | $97.56M | $7.43M | (m) | 7.90× |
| 2018-03-31 | $387.94M | $50.25M | $52.80M | $162.64M | $65.11M | $94.62M | $7.40M | (m) | 7.72× |
| 2017-12-31 | $382.23M | $51.58M | $50.64M | $163.95M | $58.01M | $94.90M | $6.76M | (m) | 7.41× |
| 2017-09-30 | $371.78M | $51.08M | $65.62M | $153.20M | $47.96M | $90.53M | $5.77M | (m) | 7.28× |
| 2017-06-30 | $364.72M | $37.51M | $76.58M | $142.07M | $48.71M | $81.14M | $4.33M | (m) | 9.72× |
| 2017-03-31 | $372.36M | $38.56M | $109.38M | $122.26M | $45.28M | $79.19M | $4.97M | (m) | 9.66× |
| 2016-12-31 | $263.83M | $35.80M | $13.24M | $115.52M | $43.34M | $73.01M | $4.11M | (m) | 7.37× |
| 2015-12-31 | $244.36M | $28.15M | $19.55M | $129.26M | $29.44M | $56.76M | $2.57M | (m) | 8.68× |
| 2015-09-30 | $249.08M | $28.28M | $159.10M | $0.00 | $26.05M | $50.32M | $4.02M | (m) | 8.81× |
| 2014-12-31 | $115.30M | $20.82M | $3.29M | $48.25M | $18.91M | $33.45M | $2.35M | (m) | 5.54× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |